1 Dermatology Unit, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Policlinico S. Orsola-Malpighi, Bologna, Italy.
2 Department of Medical and Surgical Sciences, Alma Mater Studiorum University of Bologna, Bologna, Italy.
3 Department of Dermatology, Hospital Clínic de Barcelona, University of Barcelona, Barcelona, Spain.
4 Centro de Investigación Biomédica en Red de Enfermedades Raras, Instituto de Salud Carlos III, Madrid, Spain.
5 Department of Dermatology, University Hospital Zurich, University of Zurich, Zurich, Switzerland.
6 Department of Dermatology, Netherlands Cancer Institute-Antoni van Leeuwenhoek, Amsterdam, the Netherlands.
7 Department of Dermatology, Amsterdam University Medical Center, University of Amsterdam, Amsterdam, the Netherlands.
8 First Department of Dermatology, Aristotle University, Thessaloniki, Greece.
9 Department of Dermatology-Venereology, Faculty of Medicine, National and Kapodistrian University of Athens, "A. Sygros" Hospital for Skin and Venereal Diseases, Athens, Greece.
10 Department of Dermatology and Venereology, Medical Faculty of the Military Medical Academy, University of Defense, Belgrade, Serbia.
11 Department of Dermatology, Venerology and Oncodermatology, University of Pécs, Pécs, Hungary.
12 Dermatology Unit, Department of Surgical and Medical Sciences, Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Rome, Italy.
13 Division of Medical Oncology, Fondazione Policlinico "A. Gemelli" Istituto di Ricerca e Cura a Carattere Scientifico, Rome, Italy.
14 Section of Dermatology, Department of Clinical Medicine and Surgery, University of Naples Federico II, Naples, Italy.
15 Department of Dermatology, University Hospital of Heraklion, Heraklion, Greece.
16 Dermatology Department, Hospital Germans Trias I Pujol de Badalona, Badalona, Spain.
17 Carol Davila University of Medicine and Pharmacy Bucharest, Department of Oncologic Dermatology, Elias University Hospital Bucharest, Bucharest, Romania.
18 Department of Dermatology, Hospital del Mar, Parc de Salut Mar, Institut Hospital del Mar d'Investigacions Mèdiques, Barcelona, Spain.
19 Department of Dermatology, Hospital Ruber de Juan Bravo, Universidad Europea, Madrid, Spain.
20 Dermatology Department, Hospital Italiano de Buenos Aires, Buenos Aires, Argentina.
21 Department of Dermatology, Rambam Health Care Campus.
22 The Bruce Rappaport Faculty of Medicine, Technion-Israel Institute of Technology, Haifa, Israel.
23 Institut de Cancérologie de l'Ouest, Saint-Herblain, France.
24 CHU Lille, Service de Dermatologie, Université de Lille, INSERM U1286, Lille Inflammation Translational Research Institute, Lille, France.
25 Oncodermatology Department, Institut Universitaire du Cancer, Toulouse Oncopole, Toulouse, France.
This retrospective case series compares vitiligo resulting from immune checkpoint inhibitor (ICI) therapy vs preexisting vitiligo among patients receiving ICI treatment for cancer.